Evidence map›Paper›PMID 20096706›Full record

ArticleJournal of molecular biology2010

Characterization of the interaction between diferric transferrin and transferrin receptor 2 by functional assays and atomic force microscopy.

Katsuya Ikuta, Alexandre Yersin, Atsushi Ikai, Philip Aisen, Yutaka Kohgo

Open access · greenAbstract read
In one paragraph

Article in Journal of molecular biology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Iron Metabolism in Cardiovascular Disease.Advances in experimental medicine and biology · 2025
    Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Katsuya IkutaDivision of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahikawa Medical College, 2-1-1-1 Midorigaoka-Higashi, Asahikawa, Hokkaido 078-8510, Japan. ikuta@asahikawa-med.ac.jp <ikuta@asahikawa-med.ac.jp>
Alexandre Yersin
Atsushi Ikai
Philip Aisen
Yutaka Kohgo
Asahikawa Medical College Hospital · JPTokyo Institute of Technology · JPAlbert Einstein College of Medicine · US

Funding

UPTAKE OF TRANSFERRIN AND NON-TRANSFERRIN BOUND IRON BY SFTP01DK055495 · NIDDK · YESHIVA UNIVERSITY · PI AISEN, PHILIP · 1999 to 2003
$3.5M
IRON-BINDING PROTEINS AND CONTROL OF IRON METABOLISMR01DK015056 · NIDDK · YESHIVA UNIVERSITY · PI AISEN, PHILIP · 1986 to 2001
$848k
NIDDK NIH HHS 1 PO1 DK55495NIDDK NIH HHS 5 RO1 DK015056NIDDK NIH HHS P01 DK055495NIDDK NIH HHS R01 DK015056
6 · The paper itself

Abstract

Transferrin receptor 2 (TfR2), a homologue of the classical transferrin receptor 1 (TfR1), is found in two isoforms, alpha and beta. Like TfR1, TfR2alpha is a type II membrane protein, but the beta form lacks transmembrane portions and therefore is likely to be an intracellular protein. To investigate the functional properties of TfR2alpha, we expressed the protein with FLAG tagging in transferrin-receptor-deficient Chinese hamster ovary cells. The association constant for the binding of diferric transferrin (Tf) to TfR2alpha is 5.6x10(6) M(-)(1), which is about 50 times lower than that for the binding of Tf to TfR1, with correspondingly reduced rates of iron uptake. Evidence for Tf internalization and recycling via TfR2alpha without degradation, as in the TfR1 pathway, was also found. The interaction of TfR2alpha with Tf was further investigated using atomic force microscopy, a powerful tool used for investigating the interaction between a ligand and its receptor at the single-molecule level on the living cell surface. Dynamic force microscopy reveals a difference in the interactions of Tf with TfR2alpha and TfR1, with Tf-TfR1 unbinding characterized by two energy barriers, while only one is present for Tf-TfR2. We speculate that this difference may reflect Tf binding to TfR2alpha by a single lobe, whereas two lobes of Tf participate in binding to TfR1. The difference in the binding properties of Tf to TfR1 and TfR2alpha may help account for the different physiological roles of the two receptors.

Indexed as

AnimalsAntigens, CDCHO CellsCricetinaeCricetulusHumansIronKineticsMicroscopy, Atomic ForceProtein BindingReceptors, TransferrinTransferrinAntigens, CDCD71 antigendiferric transferrinIronReceptors, TransferrinTFR2 protein, humanTransferrin

Identifiers

PMID20096706
PMCPMC2836518
OpenAlexW2031175434

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.